PharmaCyte Biotech/ US71715X2036 /
09/08/2021 00:00:00 | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
7.0000USD | - | 27,350 Turnover: - |
-Bid Size: - | -Ask Size: - | 10.0000 | 6.5700 |
GlobeNewswire
15/11/2023
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte...
GlobeNewswire
03/08/2020
PharmaCyte Biotech Ready to Submit Investigational New Drug Application to FDA for Clinical Trial in...
GlobeNewswire
29/06/2020
PharmaCyte Biotech’s COVID-19 Test Offers “Pool Testing” Dr. Fauci and White House Coronavirus Task ...
GlobeNewswire
20/04/2020
Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path t...
GlobeNewswire
13/04/2020
PharmaCyte Biotech to Offer COVID-19 Testing While Creating Revenue Stream for Pancreatic Cancer Pro...
GlobeNewswire
26/03/2020
PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic
Newsfile Corp
11/02/2020
Will PharmaCyte Biotech's Cell-in-a-Box(R) Technology Be The Game Changer To Effectively Treating Pa...
Newsfile Corp
06/02/2020
PharmaCyte Biotech Exploits Potential Of Its Cell-in-a-Box(R) Technology; Targets Billion Dollar Can...
GlobeNewswire
04/02/2020
PharmaCyte Biotech Will Have All the Protection It Needs for Pancreatic Cancer Treatment Upon Market...
GlobeNewswire
27/01/2020
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IN...
GlobeNewswire
14/01/2020
PharmaCyte Biotech Addressing Unmet Need in Patients with LAPC as Pancreatic Cancer 5-Year Survival ...
GlobeNewswire
11/12/2019
PharmaCyte Biotech Finalizes Pancreatic Cancer Treatment for U.S. FDA Approval to Begin Clinical Tri...
GlobeNewswire
12/11/2019
PharmaCyte Biotech’s “Release Testing” Last Critical Event Before Submission of Investigational New ...
GlobeNewswire
28/10/2019
PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology...
GlobeNewswire
16/10/2019
PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product
GlobeNewswire
23/09/2019
PharmaCyte Biotech's Pancreatic Cancer Therapy Production in Final Days of Key Manufacturing Run
GlobeNewswire
27/06/2019
Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Ma...
GlobeNewswire
23/01/2019
World-Renowned Oncologist Bullish on Potential of PharmaCyte’s Technology, Clinical Trial in Pancrea...
GlobeNewswire
21/09/2018
Global Pancreatic Cancer Therapy Market Analysis and Forecasts 2017-2025 - Increase in Number of The...
GlobeNewswire
06/06/2018
PharmaCyte’s Clinical Trial in Pancreatic Cancer Serves as Proving Ground for Its One of a Kind Cell...